Applying randomized controlled trial evidence

Assess patient similarities, treatment feasibility, benefits and harms, patient views, and internal validity

In relation to the statistical results and treatment effects from the article that has been critically appraised, ask these questions when making an applied clinical decision based on randomized controlled trial evidence:

1. Is the patient so different from those in the study that its results cannot apply?

2. Is the treatment feasible in the current setting?

3. What are the patient's potential benefits and harms from the therapy?

4. What are the patient's values and expectations for both the treatment and the outcome?

5. Were all the important predictor, confounding, and outcome variables considered?
Click on the Assessing Evidence-Based Practice button to continue.
Assessing Evidence-Based Practice
Back to Appraising RCT Evidence
Research Engineer Home Page

Statistician Services for Students

$50.00
Buy Now
NEED TO HIRE A STATISTICIAN?
Eric Heidel, Ph.D. will provide the following services for undergraduate and graduate students at $50/hour. Secure checkout is available with Stripe or PayPal.
  • Statistical Analysis 
  • Research Design
  • Sample Size Calculations
  • Diagnostic Testing and Epidemiological Calculations
  • Survey Design and Psychometrics
There are five considerations taken when applying randomized controlled trial evidence: Patient similarities, feasibility of treatment, harms and benefits of treatment, patient values and expectations, and all important variables are considered.

AppNotch: Convert this website into an Android and iOS app.

AppNotch team will notify you when your app gets approved in Google Play and Apple iTunes App Stores. Once your app goes live, enter your App Store URLs in this property window, publish your Weebly site and your app store icons will be visible in this page.

Please visit AppNotch.com FAQ to learn more about how to add App Store icons to your website, update your app, send Push notifications and more.